Navigation Links
EDAP Launches Enhanced Communication Plans at SIU Paris Congress
Date:9/10/2007

informative product brochures and visuals to promote the Sonolith I-sys and its multiple options.

Jerome Lavaure, Marketing Director, added: "During this event, we also launched the Ablatherm-HIFU enhanced marketing and communication plan which focuses on the role of the urological surgeon. Surgeons who offer the Ablatherm-HIFU option as a part of their clinical practice guide one of the most advanced robotic prostate cancer therapy devices available today. In offering the Ablatherm option, surgeons can go the extra mile giving localized cancer patients more treatment options and greater ability to preserve quality of life. We launched adapted communication materials including new dedicated brochures, booklets and associated messages to strengthen our positioning and capture the urological surgeon's interest."

EDAP users presented various posters and podium sessions on Ablatherm-HIFU at the SIU that confirmed superior clinical outcomes already addressed.

Dr. Conort from Hopital la Pitie Salpetriere, Paris, France, presented one poster on the outcomes of a multicentric study carried out with four university Hospitals in Paris. The study concluded that after one Ablatherm session, immediate outcomes and at six months, in terms of tolerance, were very good and remained stable. This study confirmed the very low side effects of Ablatherm-HIFU therapy as a robotized approach using proven protocols, automated safeties, and excellent ultrasound quality. In light of this prospective national study, Dr. Bensadoun, from University Hospital of Caen, France, presented a monocentric study performed on 304 patients corroborating the above very positive outcomes. These results were presented at a podium session where the urologist team from Caen shared its experience and clinical results with urologists.

Dr. Thuroff, from Harlaching Hospital in Munich, Germany, presented two videos reporting Munich's 11 years of experience with more than 1,600 treatments the
'/>"/>

SOURCE EDAP TMS S.A.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Pfizer Launches Viagra For Lung Disease In UK
8. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to ... Reduce Painkiller Overdoses (8/25), a new study found ... reduce pain have seen a significant decrease in the ... information over a ten year period, and comparing various ... able to find that there was about a 25% ...
(Date:8/29/2014)... As reported by WKMS.com in the article ... Ohio municipal court drug has come up with a new ... serves as the presiding judge in a Southeastern Ohio municipal ... addicts a medicated treatment option that can literally prevent them ... as Vivitrol, which blocks receptors in the brain that would ...
(Date:8/29/2014)... As reported by CNN.com in the article Prescription Drug ... that you need help for a prescription drug abuse problem ... fact that if you simply try to find general help ... of the information that is available online. Although the information ... still possible to get help. The statistics from SAMSHA remind ...
(Date:8/29/2014)... reported by GantDaily.com in the article NIDA Switches to ... the National Institute on Drug Abuse is taking new measures ... to social media. As NIDA currently relies on community surveillance ... the University of Maryland to create a monitoring system known ... funded by the National Institute of Health. The project is ...
(Date:8/29/2014)... USA (PRWEB) August 29, 2014 According to ... Peers, But Not Peer Pressure, Key to Prescription Drug Misuse ... the primary focus for 18-29 year olds when it comes ... that the for this age group the real problem which ... drugs, drug associations and recreational use of them to have ...
Breaking Medicine News(10 mins):Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3
... NY, October 29, 2010Women experience and interact with their natural ... in which those differences affect a woman,s sense of self, ... are explored in a thought-provoking special issue of ... Liebert, Inc. ( www.liebertpub.com ). The entire issue is available ...
... , FRIDAY, Oct. 29 (HealthDay News) -- Lack ... children with the drug-resistant staph bacteria called MRSA (methicillin-resistant ... staff need to do a better job of educating ... said the researchers at the Johns Hopkins Children Center ...
... YORK (Oct. 28, 2010) -- Scientists at Weill Cornell Medical ... and Hendra viruses, two lethal and emerging viruses for which ... could also lead to new therapies for measles, mumps and ... the prestigious journal Public Library of Science (PLoS) Pathogens ...
... - A study in the New England Journal of ... kind of lung cancer are responding positively to a treatment ... study shows 57 percent of patients with ALK-positive advanced non-small ... called crizotinib, an investigational anaplastic lymphoma kinase (ALK) inhibitor. In ...
... of Wisconsin are conducting the KAST clinical trial ... effectiveness of a new vertebral augmentation treatment (Kiva) ... osteoporosis. Sean Tutton, M.D, associate ... College, is principal interventional radiology investigator for this ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, Oct. ... the brain,s ability to detect and correct errors, such as ... , Researchers had three groups of 24 skilled typists use ... inserted typographical errors or removed them from the typed text ...
Cached Medicine News:Health News:Women's unique connection to nature is explored in special issue of Ecopsychology 2Health News:Many Parents in the Dark About Drug-Resistant Infections: Study 2Health News:Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers 2Health News:People with specific kind of lung cancer respond to new targeted treatment 2Health News:People with specific kind of lung cancer respond to new targeted treatment 3Health News:National research study to assess new treatment for painful vertebral fractures 2Health News:Brain's Error-Detection System Demystified 2
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market ... Scanner Industry, 2009-2019 is a professional and in-depth ... Crystallography Scanner industry . The report firstly reviews ... its classification, application and manufacturing technology. The report ... X-Ray Crystallography Scanner listing their product specification, capacity, ...
(Date:8/29/2014)... 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), ... support services for the lawfully organized cannabis industry, ... approved the Company,s name and symbol change request. ... be known as Chuma Holdings, Inc. ... merger with the Company,s wholly-owned subsidiary, Chuma Holdings, ...
(Date:8/29/2014)... HILL, N.C. , Aug. 29, 2014 ... Leaders (KOLs) can be the difference between a product,s ... to effectively map and stratify KOL targets – and ... build the type of strong relationships upon which successful ... research, savvy pharma companies have identified internal inconsistencies in ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... SAN DIEGO, Oct. 2 Pharmatek Laboratories, Inc., a ... industry, announced that it is the first CRO on ... the company,s preclinical and early phase clinical GMP supply ... move our customers, drug candidates into the clinic more ...
... The next major personalized medicine advances will create therapies that ... health care industry to gain access, the inventor of the ... Medical Center,s Personalized Health Care National Conference ... for Systems Biology, said personalized medicine,s first "killer apps" - ...
Cached Medicine Technology:Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast 2Personalized Medicine 'Killer Apps' Will Transform Care Model 2
Application: Capable of separating DNA fragments of 50 to 1000 bp on a 3% gel Solubility: water 15 mg/mL, clear, colorless, hot Special grade: for molecular biology Suitab tst: electrophoresis te...
Inquire...
... II (Low Melt), A low temperature ... melting temperature , Optimal for in-gel restriction ... forms a very manageable clear gel that ... Melts at approximately 65°C and remains fluid ...
... Agarose, Molecular Biology Grade, is ... of nucleic acids. It can ... fragments from 0.2 to 40 ... Agarose is tested and certified ...
Medicine Products: